In the last month, the press and medical community have been discussing the results of a recently published study showing that the use of testosterone replacement drugs can increase the risk of a heart attack, stroke or death by 29%. The fact that there were unknown risks associated with testosterone replacement therapy shouldn't come as a surprise. A study published in April of 2013 noted that despite the increasing promotion and popularity of testosterone replacement therapy, no randomized placebo-controlled trials had been conducted to ensure that the drugs are safe for long term use, despite the fact that it is thought that high levels of androgens promote cardiovascular disease.
The study titled "Testosterone Therapy and Cardiovascular Events Among Men: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Trials" reviewed and analyzed 27 previously conducted placebo-controlled randomized trials of testosterone therapy. The authors found that testosterone therapy increased the risk of a cardiovascular-related event, such as a stroke, heart attack or death. In light of these results and the numerous reports of heart attacks, strokes and deaths that occured while a man was undergoing testosterone replacement therapy, it is time for the use of testosterone replacement therapy to be re-evaluated.
If you or a loved one have suffered a heart attack or stroke after taking a testosterone replacement drug, such as Axiron, Fortesta, AndroGel, Androderm or Testim, please call our office at (888) 606-5297 for a free consultation.